172 related articles for article (PubMed ID: 33396700)
1. Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study).
Frisullo G; Profice P; Brunetti V; Scala I; Bellavia S; Broccolini A; Caliandro P; Di Iorio R; Morosetti R; Pilato F; Laborante R; Della Marca G
Brain Sci; 2020 Dec; 11(1):. PubMed ID: 33396700
[TBL] [Abstract][Full Text] [Related]
2. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
[TBL] [Abstract][Full Text] [Related]
3. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
Cappellari M; Carletti M; Danese A; Bovi P
J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
[TBL] [Abstract][Full Text] [Related]
4. Prolonged Secondary Stroke Prevention with Edoxaban: A Long-Term Follow-Up of the SATES Study.
Scala I; Bellavia S; Rizzo PA; Di Giovanni J; Monforte M; Morosetti R; Marca GD; Pilato F; Broccolini A; Profice P; Frisullo G
Brain Sci; 2023 Nov; 13(11):. PubMed ID: 38002501
[TBL] [Abstract][Full Text] [Related]
5. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two-year postmarketing surveillance study (ETNA-AF-Japan).
Yamashita T; Koretsune Y; Nagao T; Shiosakai K
J Arrhythm; 2021 Apr; 37(2):370-383. PubMed ID: 33850579
[TBL] [Abstract][Full Text] [Related]
7. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
8. Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke.
Vannucchi V; Moroni F; Grifoni E; Marcucci R; Landini G; Prisco D; Masotti L
J Thromb Thrombolysis; 2020 Jan; 49(1):86-93. PubMed ID: 31625081
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
Paciaroni M; Caso V; Agnelli G; Mosconi MG; Giustozzi M; Seiffge DJ; Engelter ST; Lyrer P; Polymeris AA; Kriemler L; Zietz A; Putaala J; Strbian D; Tomppo L; Michel P; Strambo D; Salerno A; Remillard S; Buehrer M; Bavaud O; Vanacker P; Zuurbier S; Yperzeele L; Loos CMJ; Cappellari M; Emiliani A; Zedde M; Abdul-Rahim A; Dawson J; Cronshaw R; Schirinzi E; Del Sette M; Stretz C; Kala N; Reznik M; Schomer A; Grory BM; Jayaraman M; McTaggart R; Yaghi S; Furie KL; Masotti L; Grifoni E; Toni D; Risitano A; Falcou A; Petraglia L; Lotti EM; Padroni M; Pavolucci L; Lochner P; Silvestrelli G; Ciccone A; Alberti A; Venti M; Traballi L; Urbini C; Kargiotis O; Rocco A; Diomedi M; Marcheselli S; Caliandro P; Zauli A; Reale G; Antonenko K; Rota E; Tassinari T; Saia V; Palmerini F; Aridon P; Arnao V; Monaco S; Cottone S; Baldi A; D'Amore C; Ageno W; Pegoraro S; Ntaios G; Sagris D; Giannopoulos S; Kosmidou M; Ntais E; Romoli M; Pantoni L; Rosa S; Bertora P; Chiti A; Canavero I; Saggese CE; Plocco M; Giorli E; Palaiodimou L; Bakola E; Tsivgoulis G; Bandini F; Gasparro A; Terruso V; Mannino M; Pezzini A; Ornello R; Sacco S; Popovic N; Scoditti U; Genovese A; Denti L; Flomin Y; Mancuso M; Ferrari E; Caselli MC; Ulivi L; Giannini N; De Marchis GM
Stroke; 2022 Aug; 53(8):2620-2627. PubMed ID: 35543133
[TBL] [Abstract][Full Text] [Related]
10. Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study.
Okumura K; Lip GYH; Akao M; Tanizawa K; Fukuzawa M; Abe K; Akishita M; Yamashita T
Am Heart J; 2017 Dec; 194():99-106. PubMed ID: 29223441
[TBL] [Abstract][Full Text] [Related]
11. Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.
Sezai A; Osaka S; Yaoita H; Arimoto M; Hata H; Shiono M
J Atr Fibrillation; 2016; 9(3):1456. PubMed ID: 28496931
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
13. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Goette A; Merino JL; Ezekowitz MD; Zamoryakhin D; Melino M; Jin J; Mercuri MF; Grosso MA; Fernandez V; Al-Saady N; Pelekh N; Merkely B; Zenin S; Kushnir M; Spinar J; Batushkin V; de Groot JR; Lip GY;
Lancet; 2016 Oct; 388(10055):1995-2003. PubMed ID: 27590218
[TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.
Masjuan J; DeFelipe A
Int J Neurosci; 2017 Aug; 127(8):716-725. PubMed ID: 27586690
[TBL] [Abstract][Full Text] [Related]
16. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
[TBL] [Abstract][Full Text] [Related]
17. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
Seiffge DJ; Werring DJ; Paciaroni M; Dawson J; Warach S; Milling TJ; Engelter ST; Fischer U; Norrving B
Lancet Neurol; 2019 Jan; 18(1):117-126. PubMed ID: 30415934
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
Lasek-Bal A; Urbanek T; Gierek D
Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
[TBL] [Abstract][Full Text] [Related]
19. Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study.
Sakamoto Y; Nishiyama Y; Iwasaki YK; Daida H; Toyoda K; Kitagawa K; Okumura K; Kusano K; Hagiwara N; Fujimoto S; Miyamoto S; Otsuka T; Iguchi Y; Kanamaru T; Yamamoto T; Kaburagi J; Kimura T; Matsumoto T; Kimura K; Shimizu W;
J Cardiol; 2019 Dec; 74(6):539-542. PubMed ID: 31337525
[TBL] [Abstract][Full Text] [Related]
20. Edoxaban Treatment in routiNe clinical prActice in patients with non-valvular Atrial Fibrillation (ETNA-AF) in Iberia: Baseline data.
Monteiro P
Rev Port Cardiol (Engl Ed); 2020 Nov; 39(11):651-662. PubMed ID: 33190965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
